Related Experiment Video
Updated: Aug 17, 2026

Design and Analysis for Fall Detection System Simplification
Published on: April 6, 2020
Design, monitoring, and analysis issues relative to adverse events
Abstract:
In the clinical development of new drugs for market approval, it is frequently impossible to design trials to provide definitive information about safety--particularly about adverse events. It is possible, however, to design most trials to provide definitive information about efficacy. Efficacy trials with new drugs should therefore be monitored for safety, and the safety profile described within and across trials. Confidence intervals are recommended as the appropriate statistical methodology for doing this. Such intervals provide an interval estimate on the unknown incidences of adverse experiences among patients who could be treated with each regimen, as well as permit a conclusion that two regimens are different.
Related Concept Videos
Methods of Documentation IV: Focus Charting
It typically involves three columns for recording information:
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Toxicity: Risk factors
Pharmaceutical Poisoning: Potential Scenarios
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...